Is There a Disparity Plan in Clinical Trials?

There's this omnibus bill or something that new clinical trials have to have, I think, a minority or disparity plan. Do you know anything about that? And do you have any thoughts yourself about what kind of disparity plan you would put together in a trial? Yeah, so I think it's an interesting question. In my group, actually, it started by we have an interest, my federal funding, for instance, comes in looking at basically biomarkers response to immunotherapy. One of the things that we've been looking at is particularly these motif new epitopes.